Institutional investors purchased a net $237.2 thousand shares of AMRI during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 72.89% of the shares outstanding that institutional investors hold is among the lowest in the Services to the Health Industry industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EMERALD MUTUAL FUND ADVISERS TRU... Bought 453.9 Thousand shares of Albany Molecular Research...
EMERALD ADVISERS, INC. Bought 413.7 Thousand shares of Albany Molecular Research...